🎯 check Bulevirtide (Myrcludex B) product page
Bulevirtide is a potent NTCP inhibitor. It affects viral entry signaling pathways by binding NTCP, to inhibit HBV/HDV infection.
Bulevirtide (Myrcludex B): Mechanism of Action
Bulevirtide (Myrcludex B) MOA：Targeting NTCP/Viral Entry Pathway for Chronic Hepatitis D Treatment
Jump to
- Bulevirtide (Myrcludex B) Clinical Trials
- Bulevirtide (Myrcludex B) Working Concentration | Cell Culture | Treatment
- Bulevirtide (Myrcludex B) Solubility in DMSO
- Bulevirtide (Myrcludex B) Stock Solution
- Bulevirtide (Myrcludex B) Storage
- Bulevirtide (Myrcludex B) Stability
- Bulevirtide (Myrcludex B) Combination Database
- Bulevirtide (Myrcludex B) Molecular Weight
- Bulevirtide (Myrcludex B) CAS Number
- Bulevirtide (Myrcludex B) Chemical Structure (2D and 3D)
- Bulevirtide (Myrcludex B) IC50 for Cell-based and Cell-free Assays
- Bulevirtide (Myrcludex B) Sigma (aabh9a95bc91)? Try a better option.
- Bulevirtide (Myrcludex B) MedChemExpress (HY-P3465)? Try a better option.
- Bulevirtide (Myrcludex B) APExBIO (BA1813)? Try a better option.
- Bulevirtide (Myrcludex B) SDS｜MSDS